Hematology / Oncology @Point of Care Podcasts artwork

S16:E1 – Oncology Morning Commute: Understanding the Heterogeneity of Endometrial Cancer

Hematology / Oncology @Point of Care Podcasts

English - December 31, 2022 02:00 - 25 minutes - 34.8 MB
Medicine Health & Fitness checkpointinhibitors cmece endometrialcancer immunotherapy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: S15:E3 – Oncology Morning Commute: HER2+ CRC Therapies in Clinical Practice
Next Episode: S16:E2 – Oncology Morning Commute: Is Immunotherapy Replacing Chemo in the First-Line Treatment Setting for Endometrial Cancer?

In this podcast, our faculty discuss the heterogeneity of endometrial cancer and its four molecular classifications. How do these classifications help determine patient treatment plans?


Visit www.MorningCommutePodcast.com/Endometrial3 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit.